The Patent Finder

Maintenance fees coming due

Corcept Therapeutics Incorporated

13 maintenance fees come due in the 12 months from Nov 17, 2026, the next on Dec 18, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 10,323,034Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
In force
Fee due Dec 18, 2026
Lapses if unpaid Jun 21, 2027
 · High confidence
Corcept Therapeutics, Inc.In forceDec 18, 2026Jun 21, 2027High confidence
US 11,684,612Therapeutic Uses of Relacorilant, a Heteroaryl-ketone Fused Azadecalin Glucocorticoid Receptor Modulator
In force
Fee due Dec 27, 2026
Lapses if unpaid Jun 28, 2027
 · High confidence
Corcept Therapeutics IncorporatedIn forceDec 27, 2026Jun 28, 2027High confidence
US 11,760,731Polymorphs of Pyrimidine Cyclohexyl Glucocorticoid Receptor Modulators
In force
Fee due Mar 19, 2027
Lapses if unpaid Sep 20, 2027
 · High confidence
Corcept Therapeutics IncorporatedIn forceMar 19, 2027Sep 20, 2027High confidence
US 11,787,780Quaternary Indazole Glucocorticoid Receptor Antagonists
In force
Fee due Apr 17, 2027
Lapses if unpaid Oct 18, 2027
 · High confidence
Corcept Therapeutics IncorporatedIn forceApr 17, 2027Oct 18, 2027High confidence
US 10,449,178Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
Fee due Apr 22, 2027
Lapses if unpaid Oct 22, 2027
 · High confidence
Corcept Therapeutics, Inc.In forceApr 22, 2027Oct 22, 2027High confidence
US 11,827,608Method of Preparing Pyrimidine Cyclohexyl Glucocorticoid Receptor Modulators
In force
Fee due May 28, 2027
Lapses if unpaid Nov 29, 2027
 · High confidence
Corcept Therapeutics IncorporatedIn forceMay 28, 2027Nov 29, 2027High confidence
US 11,890,289Use of Glucocorticoid Receptor Antagonists in Combination with Glucocorticoids to Treat Adrenal Insufficiency
In force
Fee due Aug 6, 2027
Lapses if unpaid Feb 7, 2028
 · High confidence
Corcept Therapeutics, Inc.In forceAug 6, 2027Feb 7, 2028High confidence
US 11,903,945Methods of Treating Antipsychotic-Induced Weight Gain with Miricorilant
In force
Fee due Aug 20, 2027
Lapses if unpaid Feb 22, 2028
 · High confidence
Corcept Therapeutics IncorporatedIn forceAug 20, 2027Feb 22, 2028High confidence
US 11,925,626Pharmaceutical Formulations Containing Relacorilant, a Heteroaryl-Ketone Fused Azadecalin Compound
In force
Fee due Sep 12, 2027
Lapses if unpaid Mar 13, 2028
 · High confidence
Corcept Therapeutics IncorporatedIn forceSep 12, 2027Mar 13, 2028High confidence
US 11,944,617Concomitant Administration of Glucocorticoid Receptor Modulator Relacorilant and Paclitaxel, a Dual Substrate of CYP2C8 and CYP3A4
In force
Fee due Oct 2, 2027
Lapses if unpaid Apr 3, 2028
 · High confidence
Corcept Therapeutics IncorporatedIn forceOct 2, 2027Apr 3, 2028High confidence
3 more maintenance fees coming due in the 12 months from Nov 17, 2026 · Pro
10 of 13 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited